Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
220 studies found for:    "Ewings family of tumors"
Show Display Options
Rank Status Study
1 Completed PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma
Condition: Ewing Family of Tumors, Rhabdomyosarcoma
Intervention: Drug: Lipegfilgrastim
2 Withdrawn A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Biological: allogeneic stem cell transplantation;   Drug: Clyclophosphamide;   Drug: Fludarabina;   Drug: Busulfan;   Drug: Melphalan
3 Recruiting Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Standard treatment (as per protocol ISG SSG III);   Drug: Intensified chemotherapy
4 Recruiting Randomized Phase IIb Trial of Vigil™ Versus Gemcitabine + Docetaxel for Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Biological: Vigil;   Drug: gemcitabine and docetaxel
5 Completed Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Condition: Non-Metastatic Ewings Sarcoma
Intervention:
6 Active, not recruiting Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults
Condition: Ewing's Sarcoma
Interventions: Drug: Chemotherapy;   Procedure: Surgery;   Radiation: Radiotherapy
7 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
8 Terminated Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
Condition: Ewing's Sarcoma
Intervention: Drug: VCR, CTX, ADM; IFO, VP-16
9 Completed Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
10 Terminated Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Interventions: Drug: Vincristine;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Dexrazoxane;   Biological: ImmTher
11 Active, not recruiting Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma
Conditions: Relapsed Ewing Sarcoma;   Refractory Ewing Sarcoma
Intervention: Drug: Linsitinib
12 Withdrawn Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Intervention: Radiation: External Beam Radiotherapy
13 Recruiting Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: Olaparib;   Drug: Temozolomide;   Drug: Irinotecan
14 Recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
15 Completed Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Drug: Olaparib
16 Recruiting ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: niraparib;   Drug: Temozolomide;   Drug: Irinotecan
17 Completed Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
Conditions: Ewing's Sarcoma;   Primitive Neuroectodermal Tumor (PNET);   Askin's Tumor of the Chest Wall;   Extraosseous Ewing's Sarcoma (EOE)
Intervention: Drug: Zalypsis
18 Recruiting Protocol for the Treatment of Metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma (ES)
Interventions: Drug: TEMIRI;   Drug: ADM;   Drug: IFO;   Drug: CYC;   Drug: ETO;   Drug: BUMEL;   Drug: VIN
19 Completed
Has Results
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Condition: Ewing's Sarcoma Family of Tumors
Intervention: Drug: CP-751,871
20 Completed
Has Results
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
Conditions: Ewing Sarcoma of Bone;   Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Interventions: Other: radiation therapy;   Other: therapeutic conventional surgery;   Drug: etoposide;   Drug: ifosfamide;   Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Drug: topotecan hydrochloride;   Biological: filgrastim

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.